Ifrd1 silencing in ductal carcinoma in situ.

Inherited susceptibility or predisposition to cancer that is epigenetically-based is poorly understood. We demonstrate here silencing of the interferon associated locus Ifrd1 in ductal carcinoma in situ in vivo.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23771541
Primary Topic
Epigenetics and DNA Methylation
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Ifrd1 silencing in ductal carcinoma in situ.

Shahan Mamoor
Zenodo (CERN European Organization for Nuclear Research)
Epigenetics and DNA Methylation
preprint

Ifrd1 silencing in ductal carcinoma in situ.

Shahan Mamoor
preprint en

Abstract

Inherited susceptibility or predisposition to cancer that is epigenetically-based is poorly understood. We demonstrate here silencing of the interferon associated locus Ifrd1 in ductal carcinoma in situ in vivo.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Epigenetics and DNA Methylation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Ifrd1 silencing in ductal carcinoma in situ. — Shahan Mamoor · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS